Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CEE PMSS (Central Eastern European Post-Marketing Surveillance Study) First Presentation of Mirapexin in Parkinson Patients

NCT00802178 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00802178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00802178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CEE PMSS (Central Eastern European Post-Marketing Surveillance Study) First Presentation of Mirapexin in Parkinson Patients
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
February 28, 2006
Completion date
Not reported
Enrollment
2,448 (actual)
Sites
311

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease